iShares China Large-Cap ETF (FXI)

Key Updates

FXI declined 2.02% to $35.59 since the June 2 report, reversing the two-session recovery and extending YTD losses to -7.06%. The selloff reflects intensifying regulatory pressure on cross-border trading platforms and mounting concerns over capital control enforcement, which overshadow earlier diplomatic progress from the Trump-Xi summit. Despite positive developments in AI-driven technology earnings and improved U.S.-China relations, Beijing's aggressive crackdown on brokerages facilitating overseas investment access signals tightening capital controls that could restrict foreign portfolio inflows and dampen investor sentiment toward Chinese equities.

Current Trend

FXI remains in a confirmed downtrend with YTD losses of -7.06% and 6-month losses of -9.25%, trading well below its October 2025 highs. The ETF has declined 11% from those peaks, underperforming broader emerging market flows. Short-term momentum shows volatility: down 2.13% in the last day, up 0.75% over 5 days, but down 2.64% over the past month. The recent two-session recovery from May 28 lows ($34.70) to June 2 highs ($36.32) proved unsustainable, with the current price of $35.59 establishing a lower high pattern. The 6-month trajectory demonstrates consistent selling pressure despite periodic relief rallies tied to diplomatic developments. Key resistance sits at $36.32 (June 2 high), while support emerges near $34.70 (May 28 low).

Investment Thesis

The investment thesis for FXI centers on China's economic stabilization following the property crisis, attractive valuations at 11x 2027 forecast earnings (half of U.S. multiples), and 15% expected earnings growth matching American levels. The $20 trillion economy has maintained record trade surpluses of $1.2 trillion in 2025 and attracted major corporate commitments including AstraZeneca's $15 billion pledge through 2030. Technology sector transformation toward AI innovation provides structural growth drivers, with Baidu reporting 49% AI revenue growth to 13.6 billion yuan and Zhipu achieving 132% revenue growth in 2025. Improved U.S.-China diplomatic relations following the Trump-Xi summit and potential tariff reductions on $30 billion in goods (approximately 10% of China's exports) support a more constructive geopolitical environment. However, the thesis faces significant headwinds from Beijing's capital control enforcement, evidenced by the securities regulator's crackdown on Futu Holdings, Up Fintech, and Longbridge Securities, which resulted in confiscation of illegal gains and mandatory account liquidation within two years. Foreign direct investment of $80 billion in 2025 remains 77% below the 2021 peak of $344 billion, reflecting persistent foreign investor caution.

Thesis Status

The investment thesis has deteriorated materially since the last report. While fundamental catalysts remain intact—including technology sector earnings growth, yuan appreciation to 6.784 (strongest since 2023), and diplomatic progress—the regulatory crackdown on cross-border trading platforms represents a structural threat to the investment case. China's securities regulator penalties on brokerages signal Beijing's intent to redirect capital toward domestic markets and limit overseas investment access, which directly conflicts with the thesis that China is becoming more investable for foreign capital. The official Qualified Domestic Institutional Investor quota of only $176 billion—a fraction of 171 trillion yuan in household savings—underscores the government's restrictive stance. Despite UBS's bullish positioning on Chinese tech stocks and Morgan Stanley's raised price targets projecting 8-12% upside, the regulatory environment creates execution risk that diminishes confidence in the near-term thesis. The valuation discount remains compelling, but capital control enforcement may prevent multiple expansion regardless of fundamental improvement.

Key Drivers

Regulatory enforcement dominates the near-term narrative. The securities regulator's crackdown on Futu Holdings, Up Fintech, and Longbridge Securities for illegally offering mainland investors overseas stock access resulted in 28% and 25% share price declines for Futu and Up Fintech respectively. This enforcement reflects Beijing's determination to control capital outflows and channel investment toward domestic markets, creating systemic risk for foreign portfolio flows. Conversely, technology sector performance provides positive momentum, with Baidu reporting 49% AI business revenue surge to 13.6 billion yuan and Zhipu posting 132% revenue growth. Global equity fund allocations to Chinese assets rose from 1.4% in early 2024 to 1.8% by February 2025, though this remains modest. Diplomatic progress continues with reports of a framework to ease tariffs on approximately $30 billion in goods, potentially reducing effective tariff rates by five percentage points. Morgan Stanley raised price targets for Chinese indexes through Q2 2027, citing improved earnings, supply chain positioning, and yuan appreciation. However, FXI remains down 11% from October highs, reflecting persistent investor caution despite institutional optimism.

Technical Analysis

FXI exhibits a bearish technical structure with lower highs and lower lows over the 6-month period. The ETF established a local bottom at $34.70 on May 28, rallied 4.67% to $36.32 by June 2, but failed to sustain momentum above $36 resistance. The current price of $35.59 represents a 2.02% decline from the June 2 high, confirming rejection at resistance and establishing a lower high pattern. The 6-month decline of -9.25% demonstrates sustained selling pressure, while the YTD loss of -7.06% indicates underperformance relative to broader emerging markets. Intraday volatility remains elevated, with the 1-day decline of -2.13% contrasting with the 5-day gain of 0.75%, suggesting choppy price action without clear directional conviction. Key technical levels: immediate resistance at $36.32 (June 2 high), secondary resistance at $36.50-$37.00 (prior consolidation zone), support at $34.70 (May 28 low), and critical support near $33.00 (representing a potential 6-month low test). The price action suggests distribution rather than accumulation, with rallies met by selling pressure. Volume patterns during the regulatory news cycle indicate institutional repositioning away from Chinese exposure.

Bull Case

• Technology sector AI-driven earnings acceleration: Baidu reported 49% AI business revenue growth to 13.6 billion yuan ($2 billion) and Zhipu achieved 132% revenue growth in 2025, demonstrating China's competitive positioning in artificial intelligence and validating the structural shift toward innovation-driven growth beyond traditional manufacturing.
• Compelling valuation discount with matching growth expectations: Chinese equities trade at 11x 2027 forecast earnings—approximately half U.S. multiples—while expected earnings growth of 15% matches American levels according to Goldman Sachs, creating significant multiple expansion potential if sentiment improves.
• Institutional price target upgrades signal professional conviction: Morgan Stanley raised price targets for Chinese indexes projecting 8-12% upside through Q2 2027 across major benchmarks, citing improved earnings, supply chain positioning, and yuan appreciation as fundamental catalysts.
• Improved U.S.-China diplomatic relations reducing geopolitical risk premium: Reports indicate the U.S. and China are considering a framework to ease tariffs on approximately $30 billion in goods, potentially reducing effective tariff rates by five percentage points and improving the trade environment.
• Yuan strength and record trade surplus supporting economic stability: China maintained record trade surpluses of $1.2 trillion in 2025 and the yuan strengthened to 6.784 against the dollar, reaching its strongest level since 2023 and signaling economic resilience post-property crisis.

Bear Case

• Aggressive capital control enforcement creating structural investment barriers: China's securities regulator imposed severe penalties on Futu Holdings, Up Fintech, and Longbridge Securities, confiscating illegal gains and mandating account liquidation within two years, demonstrating Beijing's determination to restrict overseas investment access and control capital flows.
• Foreign direct investment collapse signaling persistent investor caution: Foreign direct investment of $80 billion in 2025 remains 77% below the $344 billion peak in 2021, with private equity investors prioritizing liquid, easily-exitable positions due to regulatory unpredictability.
• Minimal official overseas investment quota restricting capital access: China's Qualified Domestic Institutional Investor program quota stands at only $176 billion—a fraction of 171 trillion yuan in household savings, limiting foreign portfolio participation and creating artificial scarcity in cross-border investment channels.
• Sustained technical weakness with lower high formation: FXI remains down 11% from October highs, failing to sustain rallies above $36 resistance despite positive diplomatic developments, indicating distribution and lack of institutional conviction.
• Modest foreign allocation increases insufficient to drive sustained rally: Global equity fund allocations to Chinese assets rose only from 1.4% to 1.8% between early 2024 and February 2025, representing marginal improvement that remains well below historical norms and insufficient to offset domestic capital control pressures.